0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Targeted and Immune Therapy
 1-20 of 277 Articles
JAMA Oncology | 
Brief Report |  ONLINE FIRST
Elizabeth M. Swisher, MD; Maria I. Harrell, PhD; Barbara M. Norquist, MD; et al.
JAMA Oncol. Published online February 04, 2016. doi:10.1001/jamaoncol.2015.6053
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Jonathan Douxfils, PharmD, PhD; Hélène Haguet, MBS; François Mullier, PharmD, PhD; et al.
JAMA Oncol. Published online February 04, 2016. doi:10.1001/jamaoncol.2015.5932
Includes: Supplemental Content

JAMA Oncology | 
Review |  ONLINE FIRST
Gary W. Jean, PharmD; Rene M. Mani, PharmD; Aliza Jaffry, PharmD; et al.
JAMA Oncol. Published online February 04, 2016. doi:10.1001/jamaoncol.2015.5927

JAMA Internal Medicine | 
Research Letter |  ONLINE FIRST
Matthew V. Abola, BA; Vinay Prasad, MD, MPH
JAMA Intern Med. Published online February 01, 2016. doi:10.1001/jamainternmed.2015.7805

JAMA Oncology | 
Editorial |  ONLINE FIRST
Javed Khan, MD; Lee J. Helman, MD
JAMA Oncol. Published online January 28, 2016. doi:10.1001/jamaoncol.2015.5685

JAMA Oncology | 
Original Investigation |  Open Access ONLINE FIRST
Marian H. Harris, MD, PhD; Steven G. DuBois, MD, MPH; Julia L. Glade Bender, MD; et al.
JAMA Oncol. Published online January 28, 2016. doi:10.1001/jamaoncol.2015.5689
Includes: Supplemental Content

JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
Steven M. Offer, PhD; Robert B. Diasio, MD
JAMA Oncol. Published online January 21, 2016. doi:10.1001/jamaoncol.2015.5463

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Valérie Boige, MD, PhD; Marc Vincent, PhD; Philippe Alexandre, MS; et al.
JAMA Oncol. Published online January 21, 2016. doi:10.1001/jamaoncol.2015.5392
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Nicholas D. James, PhD, FRCR, FRCP; Sarah J. Pirrie, MSc; Ann M. Pope, PhD; et al.
JAMA Oncol. Published online January 21, 2016. doi:10.1001/jamaoncol.2015.5570
Includes: Supplemental Content

JAMA Oncology | 
Viewpoint |  ONLINE FIRST
Caroline Wilson, MRCP, PhD; Robert Coleman, MD, FRCP
JAMA Oncol. Published online January 21, 2016. doi:10.1001/jamaoncol.2015.5768

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Julien Taieb, MD, PhD; Aziz Zaanan, MD, PhD; Karine Le Malicot, MS; et al.
JAMA Oncol. Published online January 14, 2016. doi:10.1001/jamaoncol.2015.5225
Includes: Supplemental Content

JAMA Dermatology | 
Brief Report |  ONLINE FIRST
Mina S. Ally, MD; Katherine Ransohoff, BA; Kavita Sarin, MD, PhD; et al.
JAMA Dermatol. Published online January 13, 2016. doi:10.1001/jamadermatol.2015.5473
Includes: Supplemental Content

JAMA Ophthalmology | 
Original Investigation |  ONLINE FIRST
Susan B. Bressler, MD; Allison R. Ayala, MS; Neil M. Bressler, MD; et al.
JAMA Ophthalmol. Published online January 07, 2016. doi:10.1001/jamaophthalmol.2015.5346
Includes: Supplemental Content

JAMA Oncology | 
From The JAMA Network |  ONLINE FIRST
Adam Shlien, PhD; David Malkin, MD; Uri Tabori, MD
JAMA Oncol. Published online January 07, 2016. doi:10.1001/jamaoncol.2015.5076

JAMA Oncology | 
JAMA Oncology Patient Page |  FREE
Howard (Jack) West, MD; Jill O. Jin, MD, MPH
JAMA Oncol. 2016;2(1):152. doi:10.1001/jamaoncol.2015.3488.

JAMA Dermatology | 
Observation | 
W. James Tidwell, MD; Janine Malone, MD; Jeffrey P. Callen, MD
JAMA Dermatol. 2016;152(1):105-106. doi:10.1001/jamadermatol.2015.2506.

JAMA Dermatology | 
Observation | 
Masaki Otsuka, MD; Osamu Yamasaki, MD, PhD; Tatsuya Kaji, MD; et al.
JAMA Dermatol. 2016;152(1):111-113. doi:10.1001/jamadermatol.2015.2507.

JAMA Dermatology | 
Observation | 
Anne Lynn S. Chang, MD; Jinah Kim, MD, PhD; Richard Luciano, NP; et al.
JAMA Dermatol. 2016;152(1):106-108. doi:10.1001/jamadermatol.2015.2705.

JAMA Oncology | 
JAMA Oncology Diagnostic Test Interpretation | 
Martin F. Dietrich, MD, PhD; Robert H. Collins Jr, MD; David E. Gerber, MD
JAMA Oncol. 2016;2(1):132-133. doi:10.1001/jamaoncol.2015.3788.

JAMA Oncology | 
Invited Commentary | 
Kutluk Oktay, MD, PhD; Volkan Turan, MD
JAMA Oncol. 2016;2(1):74-75. doi:10.1001/jamaoncol.2015.3252.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Brief Report  | 
Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma
Elizabeth M. Swisher, MD; Maria I. Harrell, PhD; Barbara M. Norquist, MD; et al.
JAMA Oncology
Original Investigation  | 
Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival A Systematic Review and Meta-analysis
Jonathan Douxfils, PharmD, PhD; Hélène Haguet, MBS; François Mullier, PharmD, PhD; et al.
JAMA Oncology
Review  | 
Toxic Effects of Sorafenib in Patients With Differentiated Thyroid Carcinoma Compared With Other Cancers
Gary W. Jean, PharmD; Rene M. Mani, PharmD; Aliza Jaffry, PharmD; et al.
JAMA Internal Medicine
Research Letter  | 
Characteristics and Conflicts of Public Speakers at Meetings of the Oncologic Drugs Advisory Committee to the US Food and Drug Administration
Matthew V. Abola, BA; Vinay Prasad, MD, MPH